Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers
Open
Phase 3
This trial is looking at nivolumab, relatlimab and chemotherapy for non small cell lung cancer that has spread or come back. It is comparing this to pembrolizumab and chemotherapy.
It is for people who:
are having their first treatment for non small cell lung cancer that has spread to another part of the body or has come back
have a type of non small cell lung cancer called non squamous cell
have cancer cells with a small amount of the PD-L1 protein on their surface
Recruitment start: 6 March 2025
Recruitment end: 31 July 2027
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Adam Januszewski
Bristol-Myers Squibb
Last reviewed: 13 Mar 2026
CRUK internal database number: 20145